Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess feasibility, safety and preliminary efficacy of
Extracorporeal Photopheresis in the treatment of active diffuse cutaneous systemic sclerosis
(dcSSc). This pilot study will help to determine if further study (a RCT) is justified.